Table of Contents Author Guidelines Submit a Manuscript
HPB Surgery
Volume 2014, Article ID 954604, 9 pages
http://dx.doi.org/10.1155/2014/954604
Research Article

The Prognostic Significance of Lymphatics in Colorectal Liver Metastases

Department of Surgery, The University of Melbourne and Austin Hospital, Lance Townsend Building Level 8, Studley Road, Heidelberg, Melbourne, VIC 3084, Australia

Received 4 December 2013; Accepted 16 April 2014; Published 20 May 2014

Academic Editor: Attila Olah

Copyright © 2014 Vijayaragavan Muralidharan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Warren, H. Yuan, M. R. Matli, N. A. Gillett, and N. Ferrara, “Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis,” Journal of Clinical Investigation, vol. 95, no. 4, pp. 1789–1797, 1995. View at Google Scholar · View at Scopus
  2. E. Kukk, A. Lymboussaki, S. Taira et al., “VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development,” Development, vol. 122, no. 12, pp. 3829–3837, 1996. View at Google Scholar
  3. S. S. Sundar and T. S. Ganesan, “Role of lymphangiogenesis in cancer,” Journal of Clinical Oncology, vol. 25, no. 27, pp. 4298–4307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. N. J. P. Beasley, R. Prevo, S. Banerji et al., “Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer,” Cancer Research, vol. 62, no. 5, pp. 1315–1320, 2002. View at Google Scholar · View at Scopus
  5. S.-M. Maula, M. Luukkaa, R. Grénman, D. Jackson, S. Jalkanen, and R. Ristamäki, “Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region,” Cancer Research, vol. 63, no. 8, pp. 1920–1926, 2003. View at Google Scholar · View at Scopus
  6. T. Fifis, L. Nguyen, C. Malcontenti-Wilson et al., “Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor,” Cancer Medicine, vol. 2, no. 5, pp. 595–610, 2013. View at Google Scholar
  7. H. J. Kahn, D. Bailey, and A. Marks, “Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas,” Modern Pathology, vol. 15, no. 4, pp. 434–440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Fina, H. V. Molgaard, D. Robertson et al., “Expression of the CD34 gene in vascular endothelial cells,” Blood, vol. 75, no. 12, pp. 2417–2426, 1990. View at Google Scholar · View at Scopus
  9. M. S. Pepper, “Lymphangiogenesis and tumor metastasis: myth or reality?” Clinical Cancer Research, vol. 7, no. 3, pp. 462–468, 2001. View at Google Scholar · View at Scopus
  10. J. Folkman, “Angiogenesis-dependent diseases,” Seminars in Oncology, vol. 28, no. 6, pp. 536–542, 2001. View at Google Scholar · View at Scopus
  11. J. Hasan, R. Byers, and G. C. Jayson, “Intra-tumoural microvessel density in human solid tumours,” British Journal of Cancer, vol. 86, no. 10, pp. 1566–1577, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Nguyen, T. Fifis, C. Malcontenti-Wilson et al., “Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments,” BMC Cancer, vol. 12, no. 1, p. 522, 2012. View at Google Scholar
  13. S. Banerji, J. Ni, S.-X. Wang et al., “LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan,” Journal of Cell Biology, vol. 144, no. 4, pp. 789–801, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. T. P. Padera, A. Kadambi, E. di Tomaso et al., “Lymphatic metastasis in the absence of functional intratumor lymphatics,” Science, vol. 296, no. 5574, pp. 1883–1886, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Bono, V.-M. Wasenius, P. Heikkilä, J. Lundin, D. G. Jackson, and H. Joensuu, “High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer,” Clinical Cancer Research, vol. 10, no. 21, pp. 7144–7149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kuroyama, N. Kobayashi, M. Ohbu, Y. Ohtani, I. Okayasu, and A. Kakita, “Enzyme histochemical analysis of lymphatic vessels in colon carcinoma: occurrence of lymphangiogenesis within the tumor,” Hepato-Gastroenterology, vol. 52, no. 64, pp. 1057–1061, 2005. View at Google Scholar · View at Scopus
  17. S. S. Dadras, T. Paul, J. Bertoncini et al., “Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival,” American Journal of Pathology, vol. 162, no. 6, pp. 1951–1960, 2003. View at Google Scholar · View at Scopus
  18. R. S. Saad, L. Kordunsky, Y. L. Liu, K. L. Denning, H. A. Kandil, and J. F. Silverman, “Lymphatic microvessel density as prognostic marker in colorectal cancer,” Modern Pathology, vol. 19, no. 10, pp. 1317–1323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Matsumoto, S. Natsugoe, H. Okumura et al., “Overexpression of vascular endothelial growth factor-C correlates with lymph node micrometastasis in submucosal esophageal cancer,” Journal of Gastrointestinal Surgery, vol. 10, no. 7, pp. 1016–1022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M.-A. Brundler, J. A. Harrison, B. de Saussure, M. de Perrot, and M. S. Pepper, “Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma,” Journal of Clinical Pathology, vol. 59, no. 2, pp. 191–195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. I. Auvinen, E. I. T. Sihvo, T. Ruohtula et al., “Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma,” Journal of Clinical Oncology, vol. 20, no. 13, pp. 2971–2979, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Carreira, S. M. Nasser, E. di Tomaso et al., “LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis,” Cancer Research, vol. 61, no. 22, pp. 8079–8084, 2001. View at Google Scholar · View at Scopus
  23. T. Ichida, S. Sugitani, T. Satoh et al., “Localization of hyaluronan in human liver sinu-soids: a histochemical study using hyaluronan-binding protein.,” Liver, vol. 16, pp. 365–371, 1996. View at Google Scholar
  24. R. S. Saad, J. L. Lindner, Y. Liu, and J. F. Silverman, “Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma,” American Journal of Clinical Pathology, vol. 131, no. 1, pp. 92–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Luo, L. Liu, D. Rogers et al., “Rapamycin inhibits lymphatic endothelial cell tube formation by down regulating vascular endothelial growth factor receptor 3 protein expression,” Neoplasia, vol. 14, no. 3, pp. 228–237, 2012. View at Publisher · View at Google Scholar · View at Scopus